NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for YKL-40


Results 1 - 17


Refine Search
Display Mode: Context | Summary
New atrial fibrillation study results from University of Copenhagen, Heart Center described
2009 AUG 11 ... Investigators publish new data in the report 'Plasma YKL-40, a new biomarker for atrial fibrillation.' "The aim of this study was to determine ...
Subject: Atrial Fibrillation
Price: $3.00
*
New findings reported from B. Boisselier and co-authors describe advances in glioblastoma
2009 SEP 28 ... According to a study from Paris, France, "Expression of CHI3L1 (YKL-40) has been correlated with prognosis of glioblastoma. The variant allele (-131C -> G) ...
Subject: Glioblastoma
Price: $3.00
*
New heart disease findings from Copenhagen University, Heart Center published
2009 MAY 18 ... A new study, 'High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with ...
Subject: Heart Disease
Price: $3.00
*
New sepsis study findings have been reported from N. Hattori et al
2009 NOV 2 ... by Western blotting and/or enzyme-linked immunosorbent assay for three proteins (YKL-40, lipocalin 2, and S100A9) increased in the sepsis group as well as two proteins ...
Subject: Sepsis
Price: $3.00
*
Recent findings from E.V.S. Hogdall and co-authors highlight research in ovarian cancer
2009 APR 27 ... According to recent research from Copenhagen, Denmark, "YKL-40 (chitinase-3-like-I) is a member of ''mammalian chitinase-like proteins''. ...
Subject: Ovarian Cancer
Price: $3.00
*
Reports summarize hypersensitivity study results from Yonsei University, Medical Department
2009 APR 20 ... hereditary influences. Aberrant expression of chitinase 3-like I (CHI3L1), also known as YKL-40 or HC gp-39, is involved in the pathogenesis of inflammatory and allergic ...
Subject: Hypersensitivity
Price: $3.00
*
Research conducted at S.W. Syversen and co-authors has provided new information about arthritis
2009 MAR 30 ... factor-kappa B ligand (RANKL), osteoprotegerin (OPG), human cartilage glycoprotein-39 (YKL-40), C2C, collagen cross-linked C-telopeptide (CTX-I), and cartilage oligomeric matrix ...
Subject: Arthritis
Price: $3.00
*
Research from University of California broadens understanding of stem cell research
2009 AUG 24 ... of purified CD133+, not CD133- GBM daughter cells, can lead to the development of YKL-40+ infiltrating tumors that display hypervascularity and pseudopalisading necrosis-like ...
Subject: Stem Cell Research
Price: $3.00
*
Research from University of Copenhagen in the area of type 1 diabetes published
2009 MAR 16 ... According to a study from Copenhagen, Denmark, "The inflammation marker YKL-40 is elevated in patients with type 2 diabetes and is associated with atherosclerosis and ...
Subject: Type 1 Diabetes
Price: $3.00
*
Research on chondrosarcoma described by S. Daugaard and colleagues
2009 AUG 24 ... osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit) and YKL-40. All 25 chondrosarcomas showed a positive staining reaction for D2-40, none for actin ...
Subject: Chondrosarcoma
Price: $3.00
*
Research on life sciences published by scientists at Yale University, Medical Department
2009 JUL 13 ... States, "Mouse breast regression protein 39 (BRP-39; Chi3I1) and its human homologue YKL-40 are chitinase-like proteins that lack chitinase activity. Although...
Subject: Life Sciences
Price: $3.00
*
Researchers from Chiba University, Medical Department detail findings in cancer
2009 MAR 9 ... research from Chiba, Japan, "The current study examined the clinical usefulness of YKL-40 in detection and prognosis of uterine cervical cancer. Serum levels of...
Subject: Cancer
Price: $3.00
*
Researchers from Harvard University, Department of Medicine detail new studies and findings in the area of liver disease risk factors
2009 MAY 4 -- A new study, 'The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease,' is now available. "We identified patients with nonalcoholic fatty......
Subject: Liver Disease Risk Factors
Price: $3.00
*
Studies from S. Zivanovic and colleagues yield new information about osteoarthritis
2009 SEP 7 ... "Human glycoprotein of cartilage (YKL-40) synthesises chondrocytes and synovial cells in inflammatory conditions or remodels the ...
Subject: Osteoarthritis
Price: $3.00
*
Studies from University of Athens, Department of Medicine have provided new data on melanoma therapy
2009 AUG 10 ... activity--as well as selected investigational serum biomarkers such as TA90IC and YKL-40 are also reviewed," wrote H. Gogas and colleagues, University of Athens, Department of ...
Subject: Melanoma Therapy
Price: $3.00
*
Study results from University of Copenhagen provide new insights into gastric cancer
2009 MAR 16 ... " Elevated plasma YKL-40 is a biomarker of poor prognosis in cancer patients. We tested the hypotheses that ...
Subject: Gastric Cancer
Price: $3.00
*
University of Michigan details research in hepatitis C virus
2009 APR 13 ... (HALT-C) trial were determined. Week 0, 24, 48, and 72 serum samples were analyzed for YKL-40, tissue inhibitor of matrix metalloproteinase-1, amino-terminal peptide of type III ...
Subject: Hepatitis C Virus
Price: $3.00
*

Results 1 - 17




-----------------------
PR Login